메뉴 건너뛰기




Volumn 64, Issue 4, 2015, Pages 1193-1201

Evidence for a direct effect of the NAD+ precursor acipimox on muscle mitochondrial function in humans

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACIPIMOX; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTIMIGRAINE AGENT; ATORVASTATIN; CHOLESTEROL; FATTY ACID; INSULIN; LIPID; METFORMIN; MITOCHONDRIAL PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; OMEPRAZOLE; PLACEBO; ROSUVASTATIN; SIMVASTATIN; SULFONYLUREA; TRIACYLGLYCEROL; URICOSURIC AGENT; ANTILIPEMIC AGENT; PYRAZINE DERIVATIVE;

EID: 84962030356     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-0667     Document Type: Article
Times cited : (98)

References (43)
  • 1
    • 0019513248 scopus 로고
    • Reduced triglyceridemia and increased high density lipoprotein cholesterol levels after treatment with acipimox, a new inhibitor of lipolysis
    • Sirtori CR, Gianfranceschi G, Sirtori M, et al. Reduced triglyceridemia and increased high density lipoprotein cholesterol levels after treatment with acipimox, a new inhibitor of lipolysis. Atherosclerosis 1981;38: 267-271
    • (1981) Atherosclerosis , vol.38 , pp. 267-271
    • Sirtori, C.R.1    Gianfranceschi, G.2    Sirtori, M.3
  • 2
    • 0023840497 scopus 로고
    • Effects of acipimox on serum lipids, lipoproteins and lipolytic enzymes in hypertriglyceridemia
    • Taskinen MR, Nikkilä EA. Effects of acipimox on serum lipids, lipoproteins and lipolytic enzymes in hypertriglyceridemia. Atherosclerosis 1988;69: 249-255
    • (1988) Atherosclerosis , vol.69 , pp. 249-255
    • Taskinen, M.R.1    Nikkilä, E.A.2
  • 3
    • 33644695097 scopus 로고    scopus 로고
    • Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients
    • Bajaj M, Suraamornkul S, Romanelli A, et al. Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients. Diabetes 2005;54: 3148-3153
    • (2005) Diabetes , vol.54 , pp. 3148-3153
    • Bajaj, M.1    Suraamornkul, S.2    Romanelli, A.3
  • 4
    • 33847347318 scopus 로고    scopus 로고
    • Paradoxical changes in muscle gene expression in insulinresistant subjects after sustained reduction in plasma free fatty acid concentration
    • Bajaj M, Medina-Navarro R, Suraamornkul S, Meyer C, DeFronzo RA, Mandarino LJ. Paradoxical changes in muscle gene expression in insulinresistant subjects after sustained reduction in plasma free fatty acid concentration. Diabetes 2007;56: 743-752
    • (2007) Diabetes , vol.56 , pp. 743-752
    • Bajaj, M.1    Medina-Navarro, R.2    Suraamornkul, S.3    Meyer, C.4    DeFronzo, R.A.5    Mandarino, L.J.6
  • 5
    • 84894564179 scopus 로고    scopus 로고
    • Reduction of nonesterified fatty acids improves insulin sensitivity and lowers oxidative stress, but fails to restore oxidative capacity in type 2 diabetes: A randomised clinical trial
    • Phielix E, Jelenik T, Nowotny P, Szendroedi J, Roden M. Reduction of nonesterified fatty acids improves insulin sensitivity and lowers oxidative stress, but fails to restore oxidative capacity in type 2 diabetes: A randomised clinical trial. Diabetologia 2014;57: 572-581
    • (2014) Diabetologia , vol.57 , pp. 572-581
    • Phielix, E.1    Jelenik, T.2    Nowotny, P.3    Szendroedi, J.4    Roden, M.5
  • 7
    • 58149346025 scopus 로고    scopus 로고
    • Lower intrinsic ADPstimulated mitochondrial respiration underlies in vivo mitochondrial dysfunction in muscle of male type 2 diabetic patients
    • Phielix E, Schrauwen-Hinderling VB, Mensink M, et al. Lower intrinsic ADPstimulated mitochondrial respiration underlies in vivo mitochondrial dysfunction in muscle of male type 2 diabetic patients. Diabetes 2008;57: 2943-2949
    • (2008) Diabetes , vol.57 , pp. 2943-2949
    • Phielix, E.1    Schrauwen-Hinderling, V.B.2    Mensink, M.3
  • 8
    • 0036788293 scopus 로고    scopus 로고
    • Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes
    • Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002;51: 2944-2950
    • (2002) Diabetes , vol.51 , pp. 2944-2950
    • Kelley, D.E.1    He, J.2    Menshikova, E.V.3    Ritov, V.B.4
  • 9
    • 34249681435 scopus 로고    scopus 로고
    • Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes
    • Szendroedi J, Schmid AI, Chmelik M, et al. Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes. PLoS Med 2007;4: E154
    • (2007) PLoS Med , vol.4 , pp. e154
    • Szendroedi, J.1    Schmid, A.I.2    Chmelik, M.3
  • 10
    • 0028203880 scopus 로고
    • Pronounced blood glucose-lowering effect of the antilipolytic drug acipimox in noninsulin-dependent diabetes mellitus patients during a 3-day intensified treatment period
    • Worm D, Henriksen JE, Vaag A, Thye-Rønn P, Melander A, Beck-Nielsen H. Pronounced blood glucose-lowering effect of the antilipolytic drug acipimox in noninsulin-dependent diabetes mellitus patients during a 3-day intensified treatment period. J Clin Endocrinol Metab 1994;78: 717-721
    • (1994) J Clin Endocrinol Metab , vol.78 , pp. 717-721
    • Worm, D.1    Henriksen, J.E.2    Vaag, A.3    Thye-Rønn, P.4    Melander, A.5    Beck-Nielsen, H.6
  • 11
    • 0027493805 scopus 로고
    • Metabolic consequences of sustained suppression of free fatty acids by acipimox in patients with NIDDM
    • Saloranta C, Taskinen MR, Widen E, Härkönen M, Melander A, Groop L. Metabolic consequences of sustained suppression of free fatty acids by acipimox in patients with NIDDM. Diabetes 1993;42: 1559-1566
    • (1993) Diabetes , vol.42 , pp. 1559-1566
    • Saloranta, C.1    Taskinen, M.R.2    Widen, E.3    Härkönen, M.4    Melander, A.5    Groop, L.6
  • 12
    • 50949120914 scopus 로고    scopus 로고
    • Nicotinic acid, nicotinamide, and nicotinamide riboside: A molecular evaluation of NAD+ precursor Vitamins in human nutrition
    • Bogan KL, Brenner C. Nicotinic acid, nicotinamide, and nicotinamide riboside: A molecular evaluation of NAD+ precursor Vitamins in human nutrition. Annu Rev Nutr 2008;28: 115-130
    • (2008) Annu Rev Nutr , vol.28 , pp. 115-130
    • Bogan, K.L.1    Brenner, C.2
  • 13
    • 84862022077 scopus 로고    scopus 로고
    • The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat dietinduced obesity
    • Cantó C, Houtkooper RH, Pirinen E, et al. The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat dietinduced obesity. Cell Metab 2012;15: 838-847
    • (2012) Cell Metab , vol.15 , pp. 838-847
    • Cantó, C.1    Houtkooper, R.H.2    Pirinen, E.3
  • 14
    • 84880517634 scopus 로고    scopus 로고
    • The NAD(+)/sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling
    • Mouchiroud L, Houtkooper RH, Moullan N, et al. The NAD(+)/sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling. Cell 2013;154: 430-441
    • (2013) Cell , vol.154 , pp. 430-441
    • Mouchiroud, L.1    Houtkooper, R.H.2    Moullan, N.3
  • 15
    • 80053920774 scopus 로고    scopus 로고
    • Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet-and age-induced diabetes in mice
    • Yoshino J, Mills KF, Yoon MJ, Imai S. Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet-and age-induced diabetes in mice. Cell Metab 2011;14: 528-536
    • (2011) Cell Metab , vol.14 , pp. 528-536
    • Yoshino, J.1    Mills, K.F.2    Yoon, M.J.3    Imai, S.4
  • 16
    • 31044448925 scopus 로고    scopus 로고
    • GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing
    • Benyó Z, Gille A, Kero J, et al. GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing. J Clin Invest 2005;115: 3634-3640
    • (2005) J Clin Invest , vol.115 , pp. 3634-3640
    • Benyó, Z.1    Gille, A.2    Kero, J.3
  • 18
    • 77049310862 scopus 로고
    • The gross composition of the body
    • Siri WE. The gross composition of the body. Adv Biol Med Phys 1956;4: 239-280
    • (1956) Adv Biol Med Phys , vol.4 , pp. 239-280
    • Siri, W.E.1
  • 19
    • 0018520840 scopus 로고
    • Glucose clamp technique: A method for quantifying insulin secretion and resistance
    • DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 1979;237: E214-E223
    • (1979) Am J Physiol , vol.237 , pp. E214-E223
    • DeFronzo, R.A.1    Tobin, J.D.2    Andres, R.3
  • 20
    • 0035514950 scopus 로고    scopus 로고
    • Plasma free fatty acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes
    • Mensink M, Blaak EE, van Baak MA, Wagenmakers AJ, Saris WH. Plasma free fatty acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes. Diabetes 2001;50: 2548-2554
    • (2001) Diabetes , vol.50 , pp. 2548-2554
    • Mensink, M.1    Blaak, E.E.2    Van Baak, M.A.3    Wagenmakers, A.J.4    Saris, W.H.5
  • 21
    • 33644746318 scopus 로고    scopus 로고
    • Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle
    • Brehm A, Krssak M, Schmid AI, Nowotny P, Waldhäusl W, Roden M. Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle. Diabetes 2006;55: 136-140
    • (2006) Diabetes , vol.55 , pp. 136-140
    • Brehm, A.1    Krssak, M.2    Schmid, A.I.3    Nowotny, P.4    Waldhäusl, W.5    Roden, M.6
  • 22
    • 0020576146 scopus 로고
    • Calculation of substrate oxidation rates in vivo from gaseous exchange
    • Frayn KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 1983;55: 628-634
    • (1983) J Appl Physiol , vol.55 , pp. 628-634
    • Frayn, K.N.1
  • 24
    • 0034940413 scopus 로고    scopus 로고
    • Optimisation of oil red O staining permits combination with immunofluorescence and automated quantification of lipids
    • Koopman R, Schaart G, Hesselink MK. Optimisation of oil red O staining permits combination with immunofluorescence and automated quantification of lipids. Histochem Cell Biol 2001;116: 63-68
    • (2001) Histochem Cell Biol , vol.116 , pp. 63-68
    • Koopman, R.1    Schaart, G.2    Hesselink, M.K.3
  • 25
    • 84878138385 scopus 로고    scopus 로고
    • Mitonuclear protein imbalance as a conserved longevity mechanism
    • Houtkooper RH, Mouchiroud L, Ryu D, et al. Mitonuclear protein imbalance as a conserved longevity mechanism. Nature 2013;497: 451-457
    • (2013) Nature , vol.497 , pp. 451-457
    • Houtkooper, R.H.1    Mouchiroud, L.2    Ryu, D.3
  • 26
    • 27344435774 scopus 로고    scopus 로고
    • Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
    • Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005;102: 15545-15550
    • (2005) Proc Natl Acad Sci U S A , vol.102 , pp. 15545-15550
    • Subramanian, A.1    Tamayo, P.2    Mootha, V.K.3
  • 27
    • 84865731753 scopus 로고    scopus 로고
    • The role of PARP-1 and PARP-2 enzymes in metabolic regulation and disease
    • Bai P, Cantó C. The role of PARP-1 and PARP-2 enzymes in metabolic regulation and disease. Cell Metab 2012;16: 290-295
    • (2012) Cell Metab , vol.16 , pp. 290-295
    • Bai, P.1    Cantó, C.2
  • 28
    • 79953761260 scopus 로고    scopus 로고
    • PARP-2 regulates SIRT1 expression and whole-body energy expenditure
    • Bai P, Canto C, Brunyánszki A, et al. PARP-2 regulates SIRT1 expression and whole-body energy expenditure. Cell Metab 2011;13: 450-460
    • (2011) Cell Metab , vol.13 , pp. 450-460
    • Bai, P.1    Canto, C.2    Brunyánszki, A.3
  • 29
    • 67349276169 scopus 로고    scopus 로고
    • AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
    • Cantó C, Gerhart-Hines Z, Feige JN, et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 2009;458: 1056-1060
    • (2009) Nature , vol.458 , pp. 1056-1060
    • Cantó, C.1    Gerhart-Hines, Z.2    Feige, J.N.3
  • 30
    • 65549103855 scopus 로고    scopus 로고
    • Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis
    • Ramsey KM, Yoshino J, Brace CS, et al. Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis. Science 2009;324: 651-654
    • (2009) Science , vol.324 , pp. 651-654
    • Ramsey, K.M.1    Yoshino, J.2    Brace, C.S.3
  • 31
    • 0035121962 scopus 로고    scopus 로고
    • Lipid-dependent control of hepatic glycogen stores in healthy humans
    • Stingl H, Krssák M, Krebs M, et al. Lipid-dependent control of hepatic glycogen stores in healthy humans. Diabetologia 2001;44: 48-54
    • (2001) Diabetologia , vol.44 , pp. 48-54
    • Stingl, H.1    Krssák, M.2    Krebs, M.3
  • 32
    • 0000648085 scopus 로고
    • Influences of glucose loading and of injected insulin on hepatic glucose output
    • Steele R. Influences of glucose loading and of injected insulin on hepatic glucose output. Ann N Y Acad Sci 1959;82: 420-430
    • (1959) Ann N Y Acad Sci , vol.82 , pp. 420-430
    • Steele, R.1
  • 33
    • 0027491783 scopus 로고
    • Different acute and chronic effects of acipimox treatment on glucose and lipid metabolism in patients with type 2 diabetes
    • Saloranta C, Groop L, Ekstrand A, Franssila-Kallunki A, Eriksson J, Taskinen MR. Different acute and chronic effects of acipimox treatment on glucose and lipid metabolism in patients with type 2 diabetes. Diabet Med 1993;10: 950-957
    • (1993) Diabet Med , vol.10 , pp. 950-957
    • Saloranta, C.1    Groop, L.2    Ekstrand, A.3    Franssila-Kallunki, A.4    Eriksson, J.5    Taskinen, M.R.6
  • 34
    • 0029948212 scopus 로고    scopus 로고
    • Mechanism of free fatty acid-induced insulin resistance in humans
    • Roden M, Price TB, Perseghin G, et al. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 1996;97: 2859-2865
    • (1996) J Clin Invest , vol.97 , pp. 2859-2865
    • Roden, M.1    Price, T.B.2    Perseghin, G.3
  • 35
    • 84902270555 scopus 로고    scopus 로고
    • Pharmacological Inhibition of poly(ADPribose) polymerases improves fitness and mitochondrial function in skeletal muscle
    • Pirinen E, Cantó C, Jo YS, et al. Pharmacological Inhibition of poly(ADPribose) polymerases improves fitness and mitochondrial function in skeletal muscle. Cell Metab 2014;19: 1034-1041
    • (2014) Cell Metab , vol.19 , pp. 1034-1041
    • Pirinen, E.1    Cantó, C.2    Jo, Y.S.3
  • 36
    • 0024244339 scopus 로고
    • Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM
    • Reaven GM, Hollenbeck C, Jeng CY, Wu MS, Chen YD. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 1988;37: 1020-1024
    • (1988) Diabetes , vol.37 , pp. 1020-1024
    • Reaven, G.M.1    Hollenbeck, C.2    Jeng, C.Y.3    Wu, M.S.4    Chen, Y.D.5
  • 37
    • 0024204528 scopus 로고
    • The dawn phenomenon: Its origin and contribution to early morning hyperglycemia in diabetes mellitus
    • Bolli GB. The dawn phenomenon: Its origin and contribution to early morning hyperglycemia in diabetes mellitus. Diabete Metab 1988;14: 675-686
    • (1988) Diabete Metab , vol.14 , pp. 675-686
    • Bolli, G.B.1
  • 38
    • 0025760006 scopus 로고
    • Nocturnal elevation of glucose levels during fasting in noninsulin-dependent diabetes
    • Shapiro ET, Polonsky KS, Copinschi G, et al. Nocturnal elevation of glucose levels during fasting in noninsulin-dependent diabetes. J Clin Endocrinol Metab 1991;72: 444-454
    • (1991) J Clin Endocrinol Metab , vol.72 , pp. 444-454
    • Shapiro, E.T.1    Polonsky, K.S.2    Copinschi, G.3
  • 39
    • 33748485573 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptor-gamma coactivator-1 and insulin resistance: Acute effect of fatty acids
    • Hoeks J, Hesselink MK, Russell AP, et al. Peroxisome proliferator-activated receptor-gamma coactivator-1 and insulin resistance: Acute effect of fatty acids. Diabetologia 2006;49: 2419-2426
    • (2006) Diabetologia , vol.49 , pp. 2419-2426
    • Hoeks, J.1    Hesselink, M.K.2    Russell, A.P.3
  • 40
    • 77956367951 scopus 로고    scopus 로고
    • Prolonged fasting identifies skeletal muscle mitochondrial dysfunction as consequence rather than cause of human insulin resistance
    • Hoeks J, van Herpen NA, Mensink M, et al. Prolonged fasting identifies skeletal muscle mitochondrial dysfunction as consequence rather than cause of human insulin resistance. Diabetes 2010;59: 2117-2125
    • (2010) Diabetes , vol.59 , pp. 2117-2125
    • Hoeks, J.1    Van Herpen, N.A.2    Mensink, M.3
  • 41
    • 33645526333 scopus 로고    scopus 로고
    • Effect of 6-month calorie restriction on biomarkers of longevity metabolic adaptation and oxidative stress in overweight individuals: A randomized controlled trial
    • Pennington CALERIE Team
    • Heilbronn LK, de Jonge L, Frisard MI, et al.; Pennington CALERIE Team. Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: A randomized controlled trial. JAMA 2006;295: 1539-1548
    • (2006) JAMA , vol.295 , pp. 1539-1548
    • Heilbronn, L.K.1    De Jonge, L.2    Frisard, M.I.3
  • 42
    • 77950349827 scopus 로고    scopus 로고
    • Restoration of muscle mitochondrial function and metabolic flexibility in type 2 diabetes by exercise training is paralleled by increased myocellular fat storage and improved insulin sensitivity
    • Meex RC, Schrauwen-Hinderling VB, Moonen-Kornips E, et al. Restoration of muscle mitochondrial function and metabolic flexibility in type 2 diabetes by exercise training is paralleled by increased myocellular fat storage and improved insulin sensitivity. Diabetes 2010;59: 572-579
    • (2010) Diabetes , vol.59 , pp. 572-579
    • Meex, R.C.1    Schrauwen-Hinderling, V.B.2    Moonen-Kornips, E.3
  • 43
    • 80455143206 scopus 로고    scopus 로고
    • Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans
    • Timmers S, Konings E, Bilet L, et al. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab 2011;14: 612-622
    • (2011) Cell Metab , vol.14 , pp. 612-622
    • Timmers, S.1    Konings, E.2    Bilet, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.